BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fang JM, Li J, Shi J. An update on the diagnosis of gastroenteropancreatic neuroendocrine neoplasms. World J Gastroenterol 2022; 28(10): 1009-1023 [PMID: 35431496 DOI: 10.3748/wjg.v28.i10.1009] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Gheorghișan-Gălățeanu AA, Ilieșiu A, Lambrescu IM, Țăpoi DA. The Complex Histopathological and Immunohistochemical Spectrum of Neuroendocrine Tumors-An Overview of the Latest Classifications. Int J Mol Sci 2023;24. [PMID: 36674939 DOI: 10.3390/ijms24021418] [Reference Citation Analysis]
2 Pavlidis ET, Pavlidis TE. Molecular factors, diagnosis and management of gastrointestinal tract neuroendocrine tumors: An update. World J Clin Cases 2022; 10(27): 9573-9587 [DOI: 10.12998/wjcc.v10.i27.9573] [Reference Citation Analysis]
3 Komarnicki P, Musiałkiewicz J, Stańska A, Maciejewski A, Gut P, Mastorakos G, Ruchała M. Circulating Neuroendocrine Tumor Biomarkers: Past, Present and Future. JCM 2022;11:5542. [DOI: 10.3390/jcm11195542] [Reference Citation Analysis]
4 Iabichino G, Di Leo M, Arena M, Rubis Passoni GG, Morandi E, Turpini F, Viaggi P, Luigiano C, De Luca L. Diagnosis, treatment, and current concepts in the endoscopic management of gastroenteropancreatic neuroendocrine neoplasms. World J Gastroenterol 2022; 28(34): 4943-4958 [DOI: 10.3748/wjg.v28.i34.4943] [Reference Citation Analysis]